Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02991508
Brief Title: Adrecizumab Phase 1 Trial

First Submitted : July 1, 2016
First Submitted that Met QC Criteria : December 9, 2016
First Posted : December 13, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 13, 2017
Last Update Posted : March 15, 2017